Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial

The New England Journal of Medicine
R S GibsonR E Kleiger

Abstract

We performed a multicenter, double-blind, randomized study to evaluate the effect of diltiazem on reinfarction after a non-Q-wave myocardial infarction. Nine centers enrolled 576 patients: 287 received diltiazem (90 mg every six hours) and 289 received placebo. Treatment was initiated 24 to 72 hours after the onset of infarction and continued for up to 14 days. The primary end point, reinfarction, was defined as an abnormal reelevation of MB creatine kinase in plasma within 14 days. Reinfarction occurred in 27 patients in the placebo group (9.3 percent) and in 15 in the diltiazem group (5.2 percent)--a 51.2 percent reduction in cumulative life-table incidence (P = 0.0297; 90 percent confidence interval, 7 to 67 percent). Diltiazem reduced the frequency of refractory postinfarction angina (a secondary end point) by 49.7 percent (P = 0.0345; 90 percent confidence interval, 6 to 73 percent). Mortality was similar in the two groups (3.1 and 3.8 percent, respectively, in the placebo and diltiazem groups), but adverse drug reactions (most of which were mild) were more common in the diltiazem group. Nevertheless, the drug was well tolerated, despite concurrent treatment with beta-blockers in 61 percent of the patients. We conclude tha...Continue Reading

References

Jan 1, 1979·Acta Medica Scandinavica·R Löfmark
Dec 9, 1976·The New England Journal of Medicine·J S ForresterH J Swan
Aug 1, 1985·Current Problems in Cardiology·D McCallR A O'Rourke
Sep 1, 1969·The American Journal of Physiology·A MallianiA Zanchetti
Dec 1, 1984·The American Journal of Cardiology·J T WillersonL M Buja
Nov 1, 1984·Clinical Pharmacology and Therapeutics·K F CremerJ Mehta
Apr 1, 1984·Journal of the American College of Cardiology·R W WalshR A O'Rourke
Jan 9, 1982·British Medical Journal·R H Robson, M C Vishwanath
Apr 2, 1981·The New England Journal of Medicine·UNKNOWN Norwegian Multicenter Study Group
Mar 26, 1982·JAMA : the Journal of the American Medical Association
Apr 15, 1982·The New England Journal of Medicine·G GerstenblithM L Weisfeldt
Oct 1, 1981·The American Journal of Cardiology·A MarmorR Roberts
Nov 5, 1981·The New England Journal of Medicine·E H Schuster, B H Bulkley

❮ Previous
Next ❯

Citations

Aug 1, 1997·Catheterization and Cardiovascular Diagnosis·M UnverdorbenC Vallbracht
Aug 1, 1995·Cardiovascular Drugs and Therapy·J F Hansen
Mar 1, 1988·Cardiovascular Drugs and Therapy·R Krebs
Mar 1, 1988·Cardiovascular Drugs and Therapy·W G Nayler
Dec 1, 1987·Cardiovascular Drugs and Therapy·S Yusuf, C D Furberg
Jan 1, 1991·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·P G DurandP Foëx
Aug 1, 1997·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·E ChedrawyV Nedelcu
Aug 1, 1991·Cardiovascular Drugs and Therapy·J F Hansen
Sep 1, 1987·Progress in Cardiovascular Diseases·H F Weisman, B Healy
Jun 1, 1994·International Journal of Cardiology·M A ArstallJ D Horowitz
Oct 1, 1988·Journal of the American College of Cardiology·A WisemanP Théroux
Dec 1, 1989·Journal of the American College of Cardiology·E D Frohlich
Dec 1, 1989·Journal of the American College of Cardiology·G L Bakris, E D Frohlich
Mar 1, 1989·Journal of the American College of Cardiology·A M WeisslerH Boudoulas
Sep 1, 1991·Journal of the American College of Cardiology·R Kloner, K Przyklenk
May 1, 1992·Journal of the American College of Cardiology·G Bittar
Jun 11, 1992·Journal of the American College of Cardiology·S C WongE M Dwyer
May 15, 1995·The American Journal of Cardiology·D G RizikT L Schreiber
Jul 11, 2002·The American Journal of Medicine·Peter BogatyMarie Arsenault
Oct 8, 1996·The American Journal of Medicine·E Rapaport, M Gheorghiade
Mar 1, 1997·Progress in Cardiovascular Diseases·P R Liebson, L W Klein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.